Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05445583 · ClinicalTrials.gov registry record · NA

Asthma and Technology in Emerging African American Adults

A NA study of Asthma, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
180
Enrollment target
3
Study locations

NCT05445583: Recruiting NA study of Asthma, sponsored by University of Michigan.

NCT05445583 is a NA study of Asthma that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 180 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (88% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05445583, a NA study of Asthma, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
180 participants
Enrollment target
3
Study locations

Study Summary

The purpose of the ATHENA Project is to test a mobile health intervention to help African American young adults better manage their asthma. The program has four components: 1) a web-based, mobile asthma program delivered to participants' mobile device, 2) meetings with an asthma nurse via video conference, 3) text messaging, and 4) physical activity tracking. Participants will be randomly assigned to one or more of these components to better meet the needs of young adults with asthma.

Primary Outcome

Frequency of asthma symptoms based on self-report

Conditions Studied

Asthma

Interventions

  • BEHAVIORAL Motivational Enhancement System (MES)
  • BEHAVIORAL Supportive Accountability (SA)
  • BEHAVIORAL Text Messaging (SMS)
  • BEHAVIORAL Physical Activity Tracking (PAT)

Study Locations (3)

Michigan

  • University of Michigan - Ann Arbor
  • Wayne State University - Detroit

Florida

  • Florida State University - Tallahassee

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2023-08-01
Est. Completion 2026-05-31
Phase NA
University of Michigan

1,327 total trials

What NCT05445583 shows while recruiting

NCT05445583 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (88% lower).

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 4 interventions - of which Motivational Enhancement System (MES) is the first listed.

NCT05445583 reports a single indexed study location in Michigan, Florida.

Frequently Asked Questions

What is clinical trial NCT05445583 about?

NCT05445583 is a clinical study titled "Asthma and Technology in Emerging African American Adults". The purpose of the ATHENA Project is to test a mobile health intervention to help African American young adults better manage their asthma. The program has four components: 1) a web-based, mobile asthma program delivered to participants' mobile device, 2) meetings with an asthma nurse via video conf...

What is the current status of trial NCT05445583?

This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2023-08-01. Estimated completion is 2026-05-31.

What conditions does trial NCT05445583 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT05445583?

The interventions under investigation include: Motivational Enhancement System (MES) (BEHAVIORAL), Supportive Accountability (SA) (BEHAVIORAL), Text Messaging (SMS) (BEHAVIORAL), Physical Activity Tracking (PAT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05445583?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05445583 being conducted?

This trial has 3 study locations across Florida, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05445583's enrollment target sits among peer trials

180 172nd of 374 higher than 202 of 374 other Asthma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01558804 · 180 participants

    GRoup A StrePtococcus

  • NCT02932176 · 180 participants

    Machine Learning for Handheld Vascular Studies

  • NCT03384563 · 180 participants · Phase 4

    Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane

  • NCT03423628 · 180 participants · Phase 1

    A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT05445583

Source: ClinicalTrials.gov NCT05445583, the US trial registry maintained by the National Library of Medicine. NCT05445583 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.